News Jun 13, 2025
Porton Awarded Gold Medal by EcoVadis, Ranked Among the Top 5% Globally
As a key participant in the global pharmaceutical value chain, Porton is dedicated to embedding sustainability into its corporate strategy and operations.
NewslettersJun 09, 2025
Porton Newsletter - May 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
News Jun 05, 2025
Porton Announces 2030 Sustainability Targets on World Environment Day
June 5, 2025, Chongqing — On the 54th World Environment Day, Porton Pharma Solutions Ltd. (Porton) officially announced its 2030 sustainability targets, highlighting its actions in response to the global sustainable development initiative and determination to transition into a greener future.
News May 26, 2025
Porton Pharma Solutions Celebrates 20 Years of Excellence and Innovation
Two Decades of Industry Expertise, Building Trust with Pharmaceutical Partners
News May 26, 2025
Porton Pharma Solutions Ltd. Conquers Complex POC Project Through Collaborative Innovation
In today's fast-paced biomedical technology landscape, new drug R&D is transitioning from traditional small molecules to new molecular domains, marked by increasingly complex molecular structures.
News May 23, 2025
Porton to Showcase Integrated CDMO Expertise at BOS Basel 2025
BOS Basel 2025, a premier global event for biopharmaceutical outsourcing, will convene industry leaders to address critical challenges in CMC outsourcing for Small Molecules, Biologics, and Novel Therapeutic Entities. Since its inception in Sheffield (2006), BOS Events have evolved into a refined platform featuring four key components, including a dynamic exhibition highlighting innovations from CROs and CMOs worldwide.
News May 22, 2025
Porton Advanced Announces Collaboration with TongEYE to Accelerate Development of iPSC-RPEC Transplantation Therapy
Suzhou, China, May 15, 2025 - Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with TongEye Medical Technology (TongEYE)，an innovator focusing on cell therapy drugs for ophthalmic diseases.
News May 22, 2025
Porton Advanced Announces Collaboration with Hualong Biological to Accelerate MATC Cell Therapy Development for Solid Tumor Treatment Breakthroughs
Suzhou, China, May 12, 2025 –Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Hualong Biological，an innovator in novel cancer therapeutics.
News May 16, 2025
Join Us at Chemspec Europe 2025 in June
As a benchmark exhibition in Europe, Chemspec Europe 2025 focuses on customized chemical solutions and innovative technologies. With its highly specialized positioning, the exhibition has become a core platform for global industry elites to connect resources and expand business networks. The exhibition, which covers the entire industry chain of pharmaceuticals, electronic chemicals, agricultural chemicals and other fields, is not only a hub for technology and knowledge exchange, but also an efficient channel for companies to explore the international market.
